Non-alcoholic fatty liver disease and outcomes in persons with acute coronary syndromes: insights from the GRACE-ALT analysis.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Non-alcoholic fatty liver disease (NAFLD) is associated with a higher risk of cardiovascular disease, but no data exist about the relation between NAFLD and adverse outcomes in persons with acute coronary syndromes (ACS). We evaluated elevated serum alanine aminotransferase (ALT) as a marker of NAFLD, in association adverse outcomes following ACS.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Heart Asia

Title: Heart Asia

Publisher: BMJ

ISSN: 1759-1104

ISSN (Print): 1759-1104

Publication date (Electronic): 2012

Volume: 4

Issue: 1

Affiliations

[1 ] Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.

[2 ] Division of Cardiology, Department of Medicine, St. Michael's Hospital, Toronto, Ontario, Canada; Canadian Heart Research Centre, Toronto, Ontario, Canada.

[3 ] Division of Cardiology, Department of Medicine, St. Michael's Hospital, Toronto, Ontario, Canada.

[4 ] Canadian Heart Research Centre, Toronto, Ontario, Canada.

[5 ] Division of Cardiology, Department of Medicine, St. Michael's Hospital, Toronto, Ontario, Canada; Department of Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.

Article

Publisher Item ID: heartasia-2012-010167

DOI: 10.1136/heartasia-2012-010167

PMC ID: 4832624

PubMed ID: 27326050

SO-VID: 8628f24d-b04d-4141-9091-ad82d4491dc7

History

Keywords: Coronary Artery Disease,Metabolic Medicine

Data availability:

Keywords: Coronary Artery Disease, Metabolic Medicine

Comments

Comment on this article

scite_

Cited by 3

See all cited by